First-in-the-world gene therapy delivers missing gene directly to infant's brain

An 8-month-old infant with severe genetic epilepsy has become the first patient in the world to receive an experimental gene replacement therapy designed to restore the function of the WWOX gene directly in the brain. The treatment, administered at Schneider Children's Medical Center of Israel, represents a significant milestone in the development of precision genetic therapies for rare neurological disorders.